Urological Science

CME QUIZ
Year
: 2018  |  Volume : 29  |  Issue : 3  |  Page : 172--173

Cme test


 

Correspondence Address:




How to cite this article:
. Cme test.Urol Sci 2018;29:172-173


How to cite this URL:
. Cme test. Urol Sci [serial online] 2018 [cited 2022 Sep 30 ];29:172-173
Available from: https://www.e-urol-sci.com/text.asp?2018/29/3/172/235386


Full Text

Please read this issue of Urological Science and return the postage-paid reply slip with your answers by June, 2018. A score of 80% or better will earn three CME credits.

The incidence of Infectious complications (asymptomatic UTI to septic shock) after transrectal ultrasound biopsy is?

Less than 0.11% to 4%5-10%>10%

Urol Sci 2018;29(3):129-133.

What is the median duration of metastatic prostate cancer treated with androgen deprivation therapy progressing to metastatic castration-resistant prostate cancer (mCRPC)?

<10 months11.7–16 months24-48 months48-60 months>60 months

Urol Sci 2018;29(3):136-144.

What is the risk factor of urolithiasis?

family hereditydietary habithydration status,lifestyle and environmental factorsall of the above

Urol Sci 2018;29(3):145-150.

What is the risk of prostate cancer in the patients with atypical small acinar proliferation (ASAP)

20%30%40%50%60%

Urol Sci 2018;29(2):161-165.

What is the risk of prostate cancer in the patients with high-grade prostatic intraepithelial neoplasia (HGPIN).

20%30%40%50%60%

Urol Sci 2018;29(2):161-165.

Volume 29 Issue 2

Answers:

1. (E) 2. (E) 3. (E) 4. (B) 5. (E) 6. (E)